Stephen R. Dager

Dr. Stephen R. Dager is committed to innovative research in the field of brain imaging and neuropsychiatric disorders. As a Professor of Radiology and an Adjunct Professor of Bioengineering at the University of Washington, he brings a wealth of knowledge and expertise to his work. Dr. Dager also serves as the Associate Director of the University of Washington Center on Human Development and Disability, where he plays a pivotal role in advancing research initiatives. His primary research focus is on the development and application of novel imaging techniques to study brain mechanisms underlying neuropsychiatric disorders. Dr. Dager is at the forefront of exploring how these advanced imaging methods can provide insights into the structural, metabolic, and chemical abnormalities associated with such disorders. His work is instrumental in enhancing our understanding of complex conditions like autism and caffeine addiction. Dr. Dager is currently directing several NIH-funded research projects, which are pivotal in studying brain structural, metabolic, and chemical abnormalities in neuropsychiatric disorders. His research has significant implications for the development of more effective diagnostic and therapeutic strategies, ultimately aiming to improve the quality of life for individuals affected by these conditions. In addition to his research, Dr. Dager is deeply committed to mentoring the next generation of scientists and clinicians. He actively engages with students and colleagues, fostering a collaborative environment that encourages innovation and discovery. His dedication to education and research excellence has made him a respected figure in the field of neuroimaging and neuropsychiatry. Dr. Dager's contributions to the field extend beyond his research endeavors. He is a sought-after speaker at national and international conferences, where he shares his insights and findings with the broader scientific community. His work continues to inspire and influence researchers and clinicians worldwide, driving advancements in the understanding and treatment of neuropsychiatric disorders.